Dr. Garcia-Echeverria has provided scientific leadership to drug discovery and early clinical development teams across different modalities and diseases. He currently serves as the chief of Rx creation at EQRx, leading the research and early-stage development functions. Previously, he was the chief operating officer of research at Sanofi where he oversaw the establishment and execution of the mid- and long-term vision and strategy of global research for effective portfolio management. Prior to Sanofi, Dr. Garcia-Echeverria was a member of the leadership team and global oncology decision board at the Novartis Institute for Biomedical Research. He has also broad experience in managing research partnerships. His research accomplishments are documented by 190 peer-reviewed articles, book chapters and review papers, as well as 45 granted patents.
Dr. Garcia-Echeverria holds a Ph.D. in organic chemistry from the University of Barcelona and received the Leonidas Zerwas Award from the European Peptide Society in recognition of his outstanding contributions to peptide science.